Concepedia

Ana Arance

AA

Statistics

Publications

138

Citations

33.7K

H-Index

61

Active since

2000

Affiliations

Hospital Clínic de Barcelona(Current)

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

Melanoma Institute Australia

National and Kapodistrian University of Athens

Institut Gustave Roussy

Ana Arance is an author at Hospital Clínic de Barcelona specializing in oncology, medicine, and cancer immunotherapy.

ORCID

Publications per year

2000–2025

138

Publications

138

Pembrolizumab versus Ipilimumab in Advanced Melanoma

Caroline Robert, Jacob Schachter, Georgina V. Long et al. · New England Journal of Medicine · 2015 · 5.8K citations · Full text

, , +17

Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation

Caroline Robert, Georgina V. Long, Benjamin Brady et al. · New England Journal of Medicine · 2014 · 5.4K citations · Full text

, , +14

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma

Jeffrey S. Weber, Mario Mandalà, Michele Del Vecchio et al. · New England Journal of Medicine · 2017 · 2.2K citations · Full text

, , +17

Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma

Georgina V. Long, Daniil Stroyakovskiy, Helen Gogas et al. · New England Journal of Medicine · 2014 · 1.9K citations · Full text

, , +14

Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial

Georgina V. Long, Daniil Stroyakovskiy, Helen Gogas et al. · The Lancet · 2015 · 1.4K citations

, , +7

1–5 of 138